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1. Introduction 
Gap junction is a unique intercellular channel which connects directly the cytoplasm of two 
neighbouring cells, and allows small (Mr < 1000) water-soluble molecules to travel between 
the cells throughout a tissue, thus serving as a tool of cell-cell communication (Goodenough 
et al., 1996). In general, gap junction plays crucial roles in tissue and cellular homeostasis 
and has long been known to suppress carcinogenesis in many tissues (Crespin et al., 2009; 
Leithe et al., 2006). In the liver, one of the organs where gap junctions are well developed, 
down-regulation of gap junction between hepatocytes is one of hallmarks for 
hepatocarcinogenesis (V.A. Krutovskikh et al., 1991). Gap junction is completely disrupted 
in not only hepatocellular carcinoma but also even precancerous lesions such as GST-P foci 
(Fitzgerald et al., 1989). A gap junction channel is composed of two hemichannels, which 
dock with each other to make a complete channel. Hemichannels are provided by each of 
two neighbouring cells and are called “connexons.” The connexon is a hexamer of connexin 
protein, which forms connexin family consisting of more than 20 members in mammals 
(Beyer & Berthoud, 2009; Sohl & Willecke, 2003). Among them, connexin26 and connexin32 
proteins are co-expressed in the hepatocyte (Nicholson et al., 1987; Vinken et al., 2008). 
During hepatocarcinogenesis, expression of connexin26 protein is abolished. On the other 
hand, connexin32 protein is reduced in expression but remains expressed not in plasma 
membrane but in cytoplasm, resulting in total loss of functional gap junction from both 
hepatocellular carcinoma and its precancerous lesions. More interestingly, the amount of 
connexin32 protein in cytoplasm often increases in the correspondence with tumour 
progression and/or the grade of malignancy (Fig. 1) (V. Krutovskikh et al., 1994). Therefore, 
although connexin32 protein localised in cytoplasm is non-functional as a gap junction 
component, it may contribute to tumour progression such as invasion and metastasis. 
It has long been believed that the tumour is composed of monoclonal cells and thus is a 
homogenous cell population. According to this idea, every tumour cell should have the 
ability to develop a new tumour elsewhere and possible heterogeneity should be made only 
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Fig. 1. Expression patterns and subcellular localisation of connexin26 and connexin32 
proteins in HCC. 
by spontaneous mutations during tumour development and progression. On the other 
hand, recent intensive studies have revealed that there is cellular hierarchy in a tumour 
tissue, ranging from stem-like cells to mature tumour cells (Jordan et al., 2006). This latter 
idea indicates that the tumour is per se a heterogeneous cell population and that only stem-
like cells within a tumour tissue have the ability to reconstitute a daughter tumour identical 
to its mother tumour consisting of heterogeneous cells. These two theories are not 
necessarily contradictory to each other. Since a certain mutation acquired in a single normal 
cell is the very first event of carcinogenesis, tumour cells in the same tumour are reasonably 
monoclonal. It is also true that accumulation of different mutations in individual tumour 
cells creates heterogeneity in a tumour tissue. The concept on cellular hierarchy in tumour 
tissues is not brand-new but was already proposed long time ago, i.e., in the first half of the 
20th century (Fialkow et al., 1967; Furth & Kahn, 1937), and has recently been revisited by 
many scientists with the help of various cutting-edge methods. Today, the stem-like cell is 
called “cancer stem cell (CSC)” or “tumour-initiating cell (TIC),” depending on individual 
preferences. Hereafter, CSC is applied for stem-like cell in this chapter. Usually, a tumour 
tissue contains only a very small number of CSCs and resultantly, almost all cells 
constituting a tumour mass are non-CSCs. While CSCs isolated from a tumour can develop 
a tumour when xenografted into immunodeficient animals such as SCID mice, non-CSCs 
cannot. Therefore practically, CSCs are considered to be a subpopulation having 
tumorigenicity. Since no absolute marker for CSC has so far been known in any kind of 
cancers, CSCs are indistinguishable from non-CSCs. All we can do is just to enrich CSCs 
from the bulk of a tumour by using various markers and a cell sorting system (Klonisch et 
al., 2008). For example, since CSCs of glioblastoma are contained exclusively in the CD133-
positive fraction, we can enrich them by isolating the CD133-positive fraction (Singh et al., 
2003, 2004). However, since a few non-CSCs are also CD133-positive, no means to purify 
glioblastoma CSCs have become available yet. 
CSCs of hepatocellular carcinoma (HCC) have also been investigated in many laboratories, 
some of which have succeeded in identifying the CSCs in surgical specimen (Ma et al., 2007; 
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Yang et al., 2008a, 2008b; Yin et al., 2007). Surprisingly, presence of CSCs was confirmed in 
not only HCC in vivo but also HCC-derived cell lines, including human HuH7 cells (Chiba et 
al., 2006). This finding indicates that there is cellular hierarchy even in immortalised cell 
lines and that cell lines are not always homogenous cell populations. Thus, employing 
HuH7 cells, we have investigated roles of cytoplasmic connexin32 protein in metastasis 
especially in terms of CSC population control. 
2. Cytoplasmic connexin32-mediated control of CSC population and its pro-
metastatic roles in HuH7 cells 
2.1 Cytoplasmic localisation of connexin protein in cancer 
It is universally accepted that connexin protein is a component of gap junction and thus 
localised in plasma membrane, where gap junction channels form large clusters called gap 
junction plaques (Yeager, 2009). When tissue sections are subjected to immunohistochemical 
staining, these gap junction plaques make impressive punctate signals in a cell-cell contact 
area (Momiyama et al., 2003). On the other hand, when connexin protein is retained in 
cytoplasm, their specific signals are often vague and ignored as a kind of background noises 
(Omori & Yamasaki, 1998). Finally, a certain number of surgical specimens where no gap 
junction plaques are formed are likely to be categorised as negative for connexin protein 
regardless of whether or not it is expressed in cytoplasm. 
 
Histotype of tumour Connexin Reference 
Hepatocellular carcinoma, 
moderately and poorly differentiated 
Cx32 and Cx43 V. Krutovskikh et al. (1994) 
Oyamada et al. (1990) 
Adenocarcinoma of the prostate, 
poorly differentiated 
Cx32 and Cx43 Mehta et al. (1999) 
Invasive ductal carcinoma (NOS1) of 
the breast, grade II and III 
Cx26 Jamieson et al. (1998) 
Lymph node metastases of breast 
cancer 
Cx26 and Cx43 Kanczuga-Koda et al. (2006) 
Oesophageal squamous cell 
carcinoma, poor prognostic group 
Cx26 Inose et al. (2009) 
1Not otherwise specified 
Table 1. Cytoplasmic connexin proteins in human cancers 
It is well known that gap junctional communication is severely impaired or abolished in 
almost all tumours during and after the early stage of carcinogenesis (Mesnil et al., 2005). 
Although downregulation of gap junctional communication results from a decrease in the 
expression level of connexin mRNA and/or protein in many cases (Leithe et al., 2006), 
accumulating evidences from careful studies have indicated, as shown in Table 1, that 
cytoplasmic localisation of connexin protein, probably due to a defect of membrane 
trafficking, is not rare, and that it is likely one of the mechanisms for the downregulation 
of gap junctional communication. We estimate that such cytoplasmic localisation of 
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connexin could have been observed in human tumours much more frequently than 
reported. Connexin protein in cytoplasm is non-functional as a gap junction. Does such 
cytoplasmic connexin play any roles instead of gap junction? Several reports have 
described suggestive observations on cytoplasmic connexin and tumour progression 
(Table 1). 
V. Krutovskikh et al. (1994) examined 20 surgical samples of human hepatocellular 
carcinoma for the expression pattern of connexin32 protein and found that poorly 
differentiated HCC exhibited stronger signals of connexin32 protein in cytoplasm than well 
differentiated HCC. Mehta et al. (1999) immunostained 20 primary and 20 metastatic lesions 
of human prostate cancer along with normal counterparts to detect connexin32 and 
connexin43 proteins. While both connexin32 and connexin43 proteins gave punctate signals 
in cell-cell contact areas of acinar epithelial cells in both normal and well differentiated 
adenocarcinoma tissues, both of the connexin proteins were localised in cytoplasm without 
forming gap junction plaques in poorly differentiated and undifferentiated carcinoma 
tissues. Jamieson et al. (1998) examined the immunohistochemical expression of connexin26 
and connexin43 proteins in 27 cases of invasive ductal carcinoma (not otherwise specified) 
as well as normal and benign tumour tissues of the human breast and revealed that 
connexin26 protein was expressed in cytoplasm in a great majority of the examined cancer 
samples with grade II or III malignancy while no connexin26 protein was detected in either 
normal or benign tumour samples. More interestingly, Kanczuga-Koda et al. (2006) clearly 
showed that the cytoplasmic expression of both connexin26 and connexin43 proteins was 
much more frequent in tumours that metastasised to lymph nodes than in the primary 
lesions of human breast cancers. Most recently, Inose et al. (2009) examined 123 cases of 
oesophageal squamous cell carcinoma in expression and subcellular localisation of 
connexin26 protein. While no expression of connexin26 protein was detected anywhere in 
normal counterparts, connexin26 protein was expressed in 60 cases (49%) and was localised 
in not plasma membrane but cytoplasm in these cases. Furthermore, they found the direct 
correlation between connexin26 expression and the frequency of lymph node metastases, 
suggesting that cytoplasmic expression of connexin26 protein should be related to cancer 
progression and poor prognosis rather than carcinogenesis. 
Therefore, while disruption of gap junction is a common early event during carcinogenesis, 
cytoplasmic accumulation of connexin protein seems to accelerate progression of the 
developed tumours. 
2.2 Accumulation of cytoplasmic connexin32 and enhancement of self-renewal of 
CSCs in HuH7 HCC cells 
As mentioned above, connexin32 protein translocates from plasma membrane to 
cytoplasm during hepatocarcinogenesis and its expression level correlates with the grade 
of malignancy and with the extent of progression in developed HCCs. Since the essential 
element in a cancer tissue is the CSCs but not matured tumour cells, connexin32 protein in 
cytoplasm may control progression of HCCs by modulating CSC population. 
Furthermore, the presence of CSCs in human HuH7 cells had already been proven. We, 
thus, analysed alteration of CSC population by cytoplasmic connexin32 protein in HuH7 
cells (Kawasaki et al., 2011). 
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2.2.1 Overexpression of connexin32 protein and its subcellular localisation in HCC-
derived cells 
Disruption of gap junction in association with translocation of connexin32 protein from 
plasma membrane to cytoplasm is a common feature of HCCs (V. Krutovskikh et al., 1994; 
V.A. Krutovskikh et al., 1995). Consistently, we confirmed that this aberrant expression 
pattern of connexin32 protein was conserved in liver cancer-derived cell lines such as HuH7 
(Nakabayashi et al., 1982), Li-7 (Hirohashi et al., 1979), and HepG2 (Aden et al., 1979) cells, 
the first two of which are derived from HCC and the third one is from hepatoblastoma. 
These cells are deficient in sorting of connexin32 protein into plasma membrane as is HCC. 
To examine the effects of cytoplasmic connein32 protein on CSC population, we established 
a Tet-off-based inducible expression system (Gossen & Bujard, 1992) of connexin32 in HuH7 
and Li-7 cells (Li et al., 2007). In this system, expression of exogenous connexin32 mRNA 
can be blocked by doxycycline. To the contrary, withdrawal of doxycycline from the culture 
medium induces overexpression of connexin32 mRNA and protein. As shown in Fig. 2, all 
the clones examined exhibited a significant induction. Especially, the clone 15-1 of HuH7 
Tet-off Cx32 cells expressed a 4-time-larger amount of connexin32 protein in the 
doxycycline-free medium than in the doxycycline-supplemented one. 
 
Fig. 2. Expression level of connexin32 protein in HuH7 Tet-off Cx32 and mock cells in the 
presence or absence of doxycycline. Densitometric analysis of immunoblottings for 
connexin32 protein. *p < 0.01 (n = 3) 
Since either HuH7 or Li-7 cell line has no mutation within the coding region of GJB1 (human 
connexin32 gene), the exogenous connexin32 protein is identical to the endogenous one and 
both proteins should behave in the same manner. As expected, connexin32 protein 
overexpressed in HuH7 cells was co-localised with Golgi-58K protein, as revealed by 
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immunofluorescence, in the doxycycline-deprived condition (Fig. 3), indicating that 
connexin32 protein was localised in Golgi apparatuses in HuH7 cells instead of plasma 
membrane. 
 
Fig. 3. Indirect immunofluorescence of connexin32 protein (left) and Golgi 58K protein 
(middle) in HuH7 Tet-off Cx32 cells in the absence of doxycycline. Nuclei were stained with 
diamidine phenylindole dihydrochloride. Note that signals of both connexin32 and Golgi 
58K proteins are co-localised (right). Scale bar, 20 µm. 
2.2.2 CSCs of HuH7 cells are contained exclusively in the side population 
Various CSC markers have been proposed in many cancers (Hill & Perris, 2007; Klonisch 
et al., 2008). Among them, we chose "side population" because Chiba et al. (2006) had 
already proven that CSCs of HuH7 cells are efficiently enriched in the side population 
with little contamination of non-CSCs. Besides side population, we tried another marker 
CD133, which had also been reported to be expressed in CSCs of HuH7 cells (Ma et al., 
2007; Suetsugu et al., 2006). However, CD133-positive cells accounted for ~60% of the 
whole population in HuH7 cells (Kawasaki et al., 2011; Ma et al., 2007, 2008). Although 
the CD133-positive fraction may contain the whole CSC population, the major part of 
CD133-positive fraction should consist of non-CSCs. So the efficiency of CD133-driven 
enrichment of CSCs is quite low. 
"Side population" is defined as a small subset of cells presenting a highly active efflux of 
Hoechst 33342 dye. As illustrated in Fig. 4, the side population is thus resistant to the dye 
and detected by fluorescence-activated cell sorting (FACS). On the other hand, the 
fraction which is stained with Hoechst 33342 is called “the main population.” It is well 
known that the side population is the fraction into which stem cells in normal tissues are 
efficiently enriched (Falciatori et al., 2004; Goodell et al., 1996; Shimano et al., 2003). As is 
the case not only with normal tissues, a number of recent studies on various, otherwise 
not all, malignant tumours have revealed that the cells from the side population but not 
from the main population display a series of phenotypes signifying CSC (Grichnik et al., 
2006; Hirschmann-Jax et al., 2004; Kondo et al., 2004; Moserle et al., 2008; Szotek et al., 
2006; Wang et al., 2007). 
To confirm that CSCs of our HuH7 Tet-off Cx32 cells are contained exclusively in the side 
population, we xenografted the side population and the main population subcutaneously 
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into a flank of SCID mice after cell sorting and examined tumorigenicity of the grafts 
(Table 2). While 1 x 105 cells from the side population developed a tumour at each of six 
mice examined, 1 x 105 cells from the main population could form no palpable tumours in 
any mice, indicating that the CSC population resides only in the side population in our 
HuH7 Tet-off Cx32 and mock cells as well as in parental HuH7 cells. The side population-
derived tumours are histologically identical to tumours raised from unsorted HuH7 Tet-
off Cx32 cells. 
 
Fig. 4. Schematic diagram on side and main populations. 
 
 
HuH7 Tet-off Cx32 HuH7 Tet-off Mock 
SP MP US SP MP US 
Doxycycline + - + - + - + - + - + - 
No. of mice 
bearing tumour 
6 6 0 0 2 3 6 6 0 0 3 3 
SP: side population; MP: main population; US: unsorted 
Six mice per each group were xenografted with 1 x 105 cells from each fraction. 
Table 2. Tumorigenicity of xenografts subcutaneously implanted into SCID mice 
2.2.3 Overexpression of cytoplasmic connexin32 protein expands the side population 
Considering the side population to be a CSC marker of HuH7 cells, we analysed the effects 
of cytoplasmic connexin32 protein on the CSC population by measuring the size of side 
population with FACS. In an experiment (Fig. 5), when HuH7 Tet-off Cx32 cells were 
cultured continuously for 10 days in the presence of 4 µg/ml of doxycycline, the verapamil-
sensitive side population accounted for 0.27% of the whole population. In contrast, the side 
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population in the cells cultured in a doxycycline-free medium expanded to up to 7.44% of 
the whole population. Fig. 5 shows that, in HuH7 Tet-off Cx32 cells, the proportion of the 
side population to the whole population is approximately 25 times higher in a doxycycline-
free medium than in a doxycycline-supplemented one. Such a doxycycline-dependent 
alteration of the size of side population is not observed in HuH7 Tet-off mock cells. 
Therefore, it is concluded that the cell population expressing a higher level of cytoplasmic 
connexin32 protein contains a larger side population (Kawasaki et al., 2011). 
 
Dox: doxycycline; SP: side population 
Fig. 5. FACS analysis of the side population in HuH7 Tet-off Cx32 and mock cells. 
2.2.4 Overexpression of cytoplasmic connexin32 protein enhances self-renewal of 
CSCs 
Similarly to stem cells in normal tissues, as far as maintained in monolayer culture with a 
serum-supplemented growth medium, CSCs are obliged to produce non-CSCs, which 
eventually predominate over CSCs. To avoid maturation of CSCs, they must be cultured in a 
serum-free medium on a non-attachment dish or in a serum-free semi-solid medium. In this 
condition, they proliferate as sphere-like cellular aggregates and sustain their 
undifferentiated state without maturing to non-CSCs, resulting in a pure culture of CSCs 
(Hermann et al., 2007; Kondo, 2007; Tirino et al., 2008). To define the roles of cytoplasmic 
connexin32 protein in self-renewal of CSCs, we isolated both the side population and main 
population separately by FACS and incubated each of them in a serum-free semi-solid 
medium with or without doxycycline for 20 days. As shown in Fig. 6, the main population 
had almost no capacity for sphere formation, whereas the side population exhibited an 
efficient ability to develop numerous large spheres, confirming that the side population of 
our HuH7 Tet-off Cx32 and the mock cells represented CSCs. As expected, spheres derived 
from the side population of HuH7 Tet-off Cx32 cells were increased in both number and size 
in a doxycycline-free medium compared with in a doxycycline-supplemented one (Fig. 6). 
On the other hand, the side population of HuH7 Tet-off mock cells showed similar 
capacities for sphere formation regardless of the presence or absence of doxycycline. These 
results clearly indicate that cytoplasmic accumulation of connexin32 protein enhances self-
renewal of CSCs in HuH7 cells (Kawasaki et al., 2011). 
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Fig. 6. CSC sphere formation assay in serum-free semisolid medium. The number (a) and the 
size (b) of developed CSC spheres are presented. SP: side population; MP: main population; 
Dox: doxycycline 
2.3 Cytoplasmic connexin32-mediated induction of metastasis in HuH7 cells 
As mentioned earlier, accumulation of different connexin proteins in cytoplasm has often 
been observed in cancers with high grade malignancy and/or in those of advanced stage 
(Table 1). Also in HCC, the expression level of cytoplasmic connexin32 protein is elevated as 
the differentiation state becomes poorer, strongly suggesting that accumulation of 
connexin32 protein in cytoplasm should contribute to progression of the developed HCC. 
We, thus, examined the effects of overexpression of cytoplasmic connexin32 protein on 
migration in vitro and metastasis in vivo (Li et al., 2007). 
2.3.1 Overexpression of cytoplasmic connexin32 protein enhances motility of HuH7 
cells 
Upregulation of cell motility is one of the most important steps during tumour metastasis 
(Thiery, 2002). We examined the effect of the overexpressed cytoplasmic connexin32 on 
cell motility by performing a serum-stimulated transwell migration assay (Li et al., 2007). 
Motility of all the examined clones of HuH7 Tet-off Cx32 cells was significantly 
upregulated in a doxycycline-free medium compared with in a doxycycline-
supplemented one, while doxycycline did not affect motility of HuH7 Tet-off mock cells 
(Fig. 7). Much interestingly, the Cx32-transfected HeLa cell clone which exhibited a high 
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level of gap junctional communication had a much lower motility than mock-transfected 
HeLa cells. Therefore, it is suggested that connexin32-mediated gap junctional 
communication should downregulate cell motility, which, to the contrary, cytoplasmic 
connexin32 protein upregulates. We further investigated whether overexpression of 
cytoplasmic connexin32 could affect invasiveness of HuH7 Tet-off Cx32 cells by 
evaluating the ability of HuH7 Tet-off Cx32 cells and mock cells to invade the basement 
membrane matrix in the presence or absence of doxycycline. When HuH7 Tet-off Cx32 
cells were induced to overexpress cytoplasmic connexin32 protein in a doxycycline-free 
medium, they exhibited a significantly high level of invasiveness (Li et al., 2007). 
 
Dox: doxycycline. *p < 0.01 (n = 6) 
Fig. 7. Transwell migration assay. Three clones of HuH7 Tet-off Cx32 cells and their mock 
cells as well as HeLa and Cx32-transfected HeLa cells were examined on the motility. 
2.3.2 Overexpression of cytoplasmic connexin32 protein induces a metastatic ability 
in non-metastatic HuH7 cells 
We examined how HuH7 Tet-off Cx32 cells overexpressing cytoplasmic connexin32 
protein behaved in vivo when they were grafted into the liver of immunodeficient SCID 
mice (Li et al., 2007). Each mouse was given 2 x 106 cells of HuH7 Tet-off Cx32 cells along 
with mock cells into a subserosal area of the liver and was autopsied 8 weeks after the 
implantation to observe tumour development and metastases (Fig. 8). For administration 
of doxycycline, drink water was supplemented with 2 mg/ml doxycycline throughout the 
experiment period. 
As summarised in Table 3, five out of six mice developed tumours at the implanted sites in 
each of the doxycycline (+) and the doxycycline (-) groups. The tumour sizes were not 
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distinct between the doxycycline (+) and the doxycycline (-) groups. On the other hand, 
macroscopic metastatic lesions were found in all of the five tumour-bearing mice in the 
doxycycline (-) group but in none of the mice in the doxycycline (+) group (Table 3). This 
clearly indicates that the overexpressed cytoplasmic connexin32 protein can give the 
metastatic ability to HuH7 Tet-off Cx32 cells. Micrometastases and portal vein tumour 
thrombi were also frequently observed in livers of the doxycycline (-) group given HuH7 
Tet-off Cx32 cells. 
 
Dox: doxycycline 
Fig. 8. Schematic illustration for orthotopic xenograft. 
 
Implanted cells Doxycycline 
No. of mice 
examined 
No. of mice 
bearing tumour
No. of mice with 
metastases 
HuH7 Tet-off Cx32 + 6 5 0 
 - 6 5 5 
HuH7 Tet-off mock + 4 4 0 
 - 4 4 0 
1Li et al., 2007 
Table 3. Tumorigenicity and metastasis of orthotopic xenografts in the liver of SCID mice1 
Taken together, accumulation of connexin32 protein in cytoplasm should be a pro-
metastatic event during progression of HCC. 
3. Conclusive remarks 
In this chapter, we reviewed the literatures describing cytoplasmic connexin proteins in 
different cancers including HCC and presented our previous studies demonstrating that 
accumulation of cytoplasmic conneixin32 protein enhanced self-renewal of CSCs in HCC-
derived cells and resulted in induction of metastasis. What is the impact of the number of 
CSCs upon metastasis? 
In our studies, we hypothesised that expansion of the CSC population should mediate the 
pro-metastatic function of cytoplasmic connexin32 protein. It is incontestable that cell 
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motility and invasiveness are essential factors for metastasis. What these two factors 
modulate most directly is the length of the latent period between development of a primary 
tumour and that of its first metastatic focus. On the other hand, the number of CSCs in a 
tumour should be related closely to the number of metastatic lesions that develop because 
CSCs are so-called functional seeds that are tumorigenic at a destination site of cell 
migration while non-CSCs are sterile (Fig. 9) (Jordan et al., 2006). Each metastatic lesion 
arises from a single CSC but not from non-CSCs. A recent report clearly demonstrated that 
tumour cells began to circulate in peripheral blood even at the early phase of cancer 
development, when no risk for metastasis was clinically estimated (Hüsemann et al., 2008; 
Riethdorf et al., 2008). Taken together, the proportion of CSCs to the whole population in a 
tumour should be more relevant to the extent of metastasis than the bulk of tumour cells in 
migration. So it is quite reasonable that cytoplasmic connexin32 protein should enhance the 
metastatic potential of HCC by expanding its CSC population. 
 
Fig. 9. Each metastatic tumour should be originated from a single cancer stem cell. 
For the past five decades, connexin-mediated gap junctional communication has been 
believed to be one of mechanisms for tumour suppression. This was actually the case. Gap 
junctional communication efficiently suppressed tumour development in many organs as 
revealed by both in vitro and in vivo experiments. Today, connexin proteins are, however, 
beyond gap junction (Goodenough & Paul, 2003)! A great variety of structures, functions, 
and behaviours of connexin proteins are known, i.e., hemichannel (Jiang & Gu, 2005), 
mitochondrial connexin (Boengler et al., 2005), oncogenic connexin (Banerjee et al., 2010; 
Boengler et al., 2005; Ito et al., 2000), cytoplasmic connexin (Omori et al., 2007), fragmented 
connexin, and then, gap junction. Therefore, the functions of connexin proteins in cancers 
are not always suppressive to either cell proliferation or tumour progression (Naus & Laird, 
2010). Complex and diverse functions of connexin proteins still remain to be elucidated in 
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this new era. In other words, we will acquire, in near future, novel important knowledge 
that is presently masked by connexin. 
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